Insight Molecular Diagnostics, Inc (iMDx) is dedicated to advancing precision medicine in transplantation and oncology. At iMDx, we believe that everyone deserves access to the best possible healthcare. We envision a world where critical molecular diagnostic tests are accessible to all.
Our mission is to democratize access to cutting-edge diagnostic solutions by making precision medicine more widely available through both clinical testing and research-driven collaborations. By empowering physicians, researchers, and patients with clear, actionable insights, we help drive informed decision-making and better health outcomes.
Behind every test is a person—a patient awaiting answers and a physician seeking the best path forward. This profound responsibility fuels our commitment to innovation. We develop diagnostic solutions that are not only scientifically advanced but also practical and accessible, ensuring they deliver clear, reliable results when they matter most.
Through partnerships with leading physicians, institutions, and researchers worldwide, we push the boundaries of scientific discovery. Our research-use-only (RUO) solutions enable laboratories to bring tests in-house, accelerating progress in both oncology and transplant management, while our IVD products will enable local patient management and value capture.
Delivering accurate, timely insights for earlier detection and personalized treatment strategies.
Reducing the financial burden on patients and healthcare systems through precision-driven democratized diagnostics.
Developing powerful diagnostic solutions that address unmet medical needs and improve the standard of care.
Patients are at the heart of everything we do. Our diagnostic solutions are designed to provide meaningful insights that enhance patient outcomes.
We uphold the highest ethical and scientific standards, fostering trust among colleagues, partners, healthcare providers, and the patients we serve.
We empower our employees to take bold steps, viewing challenges as opportunities for growth and innovation.
Our dedication to progress drives us to develop cutting-edge diagnostic solutions that empower healthcare providers and patients alike.
We believe in the power of collaboration. By working together, we enhance our effectiveness and create a supportive environment that amplifies success for all.
We provide both clinical and research-use solutions designed to improve patient outcomes:
A blood-based test that detects early signs of organ rejection post-transplant, helping physicians adjust treatments proactively.
A research-use-only solution that enables scientists to refine transplant monitoring strategies and drive future innovations in post-transplant care.
(in development) A clinical assay that can be used to bring an important tool in transplant patient surveillance to where it needs to be—at the place where the patient is treated.
A revolutionary test that analyzes a tumor’s microenvironment, helping oncologists determine whether a patient is likely to respond to immunotherapy.
(in development) A non-invasive cancer monitoring tool that tracks how a patient’s cancer is responding to treatment, enabling real-time therapy adjustments.
Enables decentralized, high-quality research on the tumor immune microenvironment to support discovery, biomarker validation, and drive future innovations in oncology.
At iMDx, we believe that innovation must be matched with integrity and compassion. Our CLIA-certified and CAP-accredited laboratories uphold the highest standards, ensuring that every result we deliver is accurate, reliable, and clinically meaningful.
By making advanced molecular diagnostics more accessible, we are shaping a future where early detection, personalized treatment, and better patient outcomes are the norm.
At iMDx, we believe that by working together, we can transform healthcare and improve lives.
We are always looking for dedicated individuals to join our mission. If you’re passionate about improving patient care and driving medical discovery, explore our career opportunities and join us in shaping the future of healthcare.
©2025 Insight Molecular Diagnostics Inc. All rights reserved. iMDx, GraftAssureCore, GraftAssureIQ, GraftAssureDx, DetermaIO, DetermaCNI, and OncoTIME are trademarks of Insight Molecular Diagnostics Inc. All other trademarks are the property of their respective owners. For the intended uses of all products, please refer to www.imdxinc.com.
WEBSITE BY: LEFT HAND DESIGN
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
iMDx Terms and Conditions of Sale shall govern the sale and purchase of the products quoted herein. Please see Terms and Conditions for additional details.
